AR050732A1 - 15 beta-sustituidos esteroides con actividad estrogenica selectiva - Google Patents
15 beta-sustituidos esteroides con actividad estrogenica selectivaInfo
- Publication number
- AR050732A1 AR050732A1 ARP050103745A ARP050103745A AR050732A1 AR 050732 A1 AR050732 A1 AR 050732A1 AR P050103745 A ARP050103745 A AR P050103745A AR P050103745 A ARP050103745 A AR P050103745A AR 050732 A1 AR050732 A1 AR 050732A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- beta
- selective
- activity
- strogen
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 2
- 150000003431 steroids Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 230000003637 steroidlike Effects 0.000 abstract 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 1
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 abstract 1
- 125000006593 (C2-C3) alkynyl group Chemical group 0.000 abstract 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 102000015694 estrogen receptors Human genes 0.000 abstract 1
- 108010038795 estrogen receptors Proteins 0.000 abstract 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 abstract 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04104334 | 2004-09-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR050732A1 true AR050732A1 (es) | 2006-11-15 |
Family
ID=34929554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050103745A AR050732A1 (es) | 2004-09-08 | 2005-09-08 | 15 beta-sustituidos esteroides con actividad estrogenica selectiva |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7838516B2 (https=) |
| EP (1) | EP1805201B1 (https=) |
| JP (1) | JP4889644B2 (https=) |
| AR (1) | AR050732A1 (https=) |
| AT (1) | ATE414710T1 (https=) |
| AU (1) | AU2005281705B2 (https=) |
| BR (1) | BRPI0514976A (https=) |
| CA (1) | CA2577497C (https=) |
| DK (1) | DK1805201T3 (https=) |
| ES (1) | ES2317312T3 (https=) |
| NZ (1) | NZ553266A (https=) |
| PE (1) | PE20060590A1 (https=) |
| PL (1) | PL1805201T3 (https=) |
| PT (1) | PT1805201E (https=) |
| RS (1) | RS51640B (https=) |
| RU (1) | RU2386637C2 (https=) |
| SI (1) | SI1805201T1 (https=) |
| TW (1) | TW200621795A (https=) |
| UA (1) | UA89964C2 (https=) |
| WO (1) | WO2006027347A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8030298B2 (en) | 2005-05-26 | 2011-10-04 | Abbott Products Gmbh | 17β-HSD1 and STS inhibitors |
| US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
| US8288367B2 (en) | 2006-11-30 | 2012-10-16 | Solvay Pharmaceuticals Gmbh | Substituted estratriene derivatives as 17BETA HSD inhibitors |
| JP5749261B2 (ja) * | 2009-06-29 | 2015-07-15 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | ３，３，５，５−テトラメチルシクロヘキサノンを調製する方法 |
| JP5738854B2 (ja) * | 2009-06-29 | 2015-06-24 | メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー | ネラメキサンの製造方法 |
| EP2448908B1 (en) * | 2009-06-29 | 2013-09-18 | Merz Pharma GmbH & Co. KGaA | Method of preparing neramexane |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| EP2764008B1 (en) * | 2011-10-07 | 2016-08-17 | Estetra S.P.R.L. | Process for the production of estetrol |
| WO2014207311A1 (en) | 2013-06-25 | 2014-12-31 | Forendo Pharma Ltd | Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxy-steroid dehydrogenase, type 1 |
| US10377791B2 (en) | 2013-06-25 | 2019-08-13 | Forendo Pharma Ltd. | Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1 |
| KR20160042873A (ko) | 2013-06-25 | 2016-04-20 | 포렌도 파마 리미티드 | 17.베타.-하이드록시스테로이드 탈수소효소의 억제제로서 치료적 활성 17-질소 치환된 에스트라트리엔티아졸 유도체 |
| CN107207561B (zh) | 2014-12-23 | 2020-03-31 | 佛恩多制药有限公司 | 17β-HSD1–抑制剂的前药 |
| US10626140B2 (en) | 2014-12-23 | 2020-04-21 | Forendo Pharma Ltd | Prodrugs of 17β-HSD1-inhibitors |
| MD3310333T2 (ro) | 2015-06-18 | 2020-06-30 | Estetra Sprl | Unitate de dozare orodispersabilă care conține un component estetrol |
| CN116077454A (zh) | 2015-06-18 | 2023-05-09 | 埃斯特拉有限责任公司 | 含雌四醇组分的口腔分散剂量单位 |
| RS61777B1 (sr) | 2015-06-18 | 2021-06-30 | Estetra Sprl | Oralno-disperzibilna tableta koja sadrži estetrol |
| HUE054589T2 (hu) | 2015-06-18 | 2021-09-28 | Estetra Sprl | Szájban diszpergálódó esztetrol tartalmú tabletta |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| FI3634975T3 (fi) | 2017-06-08 | 2024-05-03 | Organon R&D Finland Ltd | 15-beeta-[3-propanamido]substituoitujen estra-1,3,5(10)-trien-17-onien 17-oksiimeja käytettäväksi 17-beeta-hydroksisteroididehydrogenaasien inhiboimisessa |
| DK3781171T3 (da) | 2018-04-19 | 2022-05-02 | Estetra Srl | Sammensætninger og deres anvendelser til lindring af menopause-associerede symptomer |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| BR112021010598A2 (pt) | 2018-12-05 | 2021-08-24 | Forendo Pharma Ltd | Compostos, método para preparação de um composto e composição farmacêutica |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1084261B (de) | 1957-04-11 | 1960-06-30 | Syntex Sa | Verfahren zur Herstellung neuer Cyclopentanophenanthrenderivate |
| NL226738A (https=) | 1957-04-11 | |||
| US3257429A (en) * | 1957-11-12 | 1966-06-21 | Syntex Corp | 16-methylene derivatives of estrone and estradiol |
| US3007946A (en) | 1958-11-06 | 1961-11-07 | Searle & Co | 3-alkoxy-16-methylene-1, 3, 5(10)-estratrien-17-ones |
| US3049555A (en) | 1959-12-22 | 1962-08-14 | Searle & Co | 3-alkoxy-16-methyl-1, 3, 5 (10)-estratrien-17-ones |
| US3092645A (en) | 1961-12-28 | 1963-06-04 | Searle & Co | Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols |
| GB1112840A (en) | 1964-04-07 | 1968-05-08 | Res Inst Medicine Chem | Steroids having pro-oestrogenic activity |
| US3299108A (en) | 1965-10-18 | 1967-01-17 | Searle & Co | 17alpha-alkynyl/alkenyl-13beta-alkyl-11-alkylgona-1, 3, 5 (10)-triene-3, 17beta-diols, ethers and esters thereof and intermediates thereto |
| US3465010A (en) | 1966-11-22 | 1969-09-02 | Searle & Co | 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof |
| US3377366A (en) | 1966-12-02 | 1968-04-09 | Searle & Co | 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof |
| US3642992A (en) * | 1967-09-08 | 1972-02-15 | Upjohn Co | Organic compounds |
| ZA712312B (en) | 1970-04-28 | 1972-01-26 | Ochsner Med Found Alton | 4,14-estradiene compounds |
| US3652606A (en) | 1970-08-07 | 1972-03-28 | Searle & Co | 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof |
| US3704253A (en) | 1970-09-23 | 1972-11-28 | American Home Prod | 13 - polycarbonalkyl - 16 - methylgona-1,3,5(10)-trienes and 13-polycarbonalkyl-16-methylgon - 4 - en-3-ones and intermediates for their production |
| US3766224A (en) * | 1971-06-03 | 1973-10-16 | Sandoz Ag | 15-methyl-substituted steroids |
| FR2377419A1 (fr) | 1977-01-13 | 1978-08-11 | Roussel Uclaf | Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament |
| DE2757157C3 (de) | 1977-12-19 | 1980-10-09 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 16 a -alkylierten Steroiden |
| AU572589B2 (en) | 1983-12-14 | 1988-05-12 | Upjohn Company, The | 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids |
| US5116830A (en) | 1984-08-17 | 1992-05-26 | Sri International | Stereoisomerically pure 17α-ethynyl-estra-2-en-17β-ol and the 17β esters thereof, methods of preparation and uses |
| US5204337A (en) | 1988-10-31 | 1993-04-20 | Endorecherche Inc. | Estrogen nucleus derivatives for use in inhibition of sex steroid activity |
| ZA94715B (en) | 1993-02-08 | 1994-10-24 | Akzo Nv | Steroids for treating menopausal complaints |
| ES2134313T3 (es) | 1993-03-05 | 1999-10-01 | Akzo Nobel Nv | Utilizacion de derivados de pregnano para el tratamiento de tumores. |
| CA2200423C (en) | 1996-03-26 | 2006-12-19 | Sietse Mosselman | Novel estrogen receptor |
| TW403736B (en) | 1997-02-21 | 2000-09-01 | Akzo Nobel Nv | Steroid compounds having contraceptive and anti-osteoporosis activity |
| WO1999045886A2 (en) | 1998-03-09 | 1999-09-16 | Akzo Nobel N.V. | New contraceptive kit for monotherapy |
| NZ508299A (en) | 1998-06-19 | 2003-04-29 | Akzo Nobel Nv | Testosterone derivative |
| DE69902684T2 (de) | 1998-11-20 | 2003-04-24 | Akzo Nobel N.V., Arnheim/Arnhem | Estrogenische estra-1,3,5(10)-trien verbindungen mit verschiedenen wirkungen auf estrogenrezeptor alpha und beta mit einer unverzweigten kohlenwasserstoffkette von 5-9 kohlenstoffatomen in position 11 |
| TW548277B (en) | 1999-07-16 | 2003-08-21 | Akzo Nobel Nv | Orally active androgens |
| US6677329B1 (en) | 1999-09-06 | 2004-01-13 | Akzo Nobel N V. | Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| DE50014299D1 (de) * | 1999-11-02 | 2007-06-14 | Bayer Schering Pharma Ag | 18-nor-steroide als selektiv wirksame estrogene |
| AU8201601A (en) * | 2000-07-28 | 2002-02-13 | Akzo Nobel Nv | 16alpha-methyl or ethyl substituted estrogens |
-
2005
- 2005-05-09 UA UAA200701655A patent/UA89964C2/ru unknown
- 2005-09-02 TW TW094130148A patent/TW200621795A/zh unknown
- 2005-09-05 DK DK05794597T patent/DK1805201T3/da active
- 2005-09-05 RU RU2007112939/04A patent/RU2386637C2/ru not_active IP Right Cessation
- 2005-09-05 CA CA2577497A patent/CA2577497C/en not_active Expired - Fee Related
- 2005-09-05 US US11/662,166 patent/US7838516B2/en active Active
- 2005-09-05 AU AU2005281705A patent/AU2005281705B2/en not_active Ceased
- 2005-09-05 RS RS20070075A patent/RS51640B/sr unknown
- 2005-09-05 BR BRPI0514976-2A patent/BRPI0514976A/pt not_active IP Right Cessation
- 2005-09-05 AT AT05794597T patent/ATE414710T1/de active
- 2005-09-05 JP JP2007530702A patent/JP4889644B2/ja not_active Expired - Fee Related
- 2005-09-05 NZ NZ553266A patent/NZ553266A/en not_active IP Right Cessation
- 2005-09-05 SI SI200530582T patent/SI1805201T1/sl unknown
- 2005-09-05 PT PT05794597T patent/PT1805201E/pt unknown
- 2005-09-05 EP EP05794597A patent/EP1805201B1/en not_active Expired - Lifetime
- 2005-09-05 WO PCT/EP2005/054368 patent/WO2006027347A1/en not_active Ceased
- 2005-09-05 ES ES05794597T patent/ES2317312T3/es not_active Expired - Lifetime
- 2005-09-05 PL PL05794597T patent/PL1805201T3/pl unknown
- 2005-09-06 PE PE2005001026A patent/PE20060590A1/es not_active Application Discontinuation
- 2005-09-08 AR ARP050103745A patent/AR050732A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7838516B2 (en) | 2010-11-23 |
| UA89964C2 (ru) | 2010-03-25 |
| JP2008512426A (ja) | 2008-04-24 |
| DK1805201T3 (da) | 2009-01-12 |
| PL1805201T3 (pl) | 2009-04-30 |
| TW200621795A (en) | 2006-07-01 |
| US20070254860A1 (en) | 2007-11-01 |
| EP1805201B1 (en) | 2008-11-19 |
| RS51640B (sr) | 2011-10-31 |
| RU2386637C2 (ru) | 2010-04-20 |
| WO2006027347A1 (en) | 2006-03-16 |
| EP1805201A1 (en) | 2007-07-11 |
| PE20060590A1 (es) | 2006-07-14 |
| ATE414710T1 (de) | 2008-12-15 |
| SI1805201T1 (sl) | 2009-04-30 |
| ES2317312T3 (es) | 2009-04-16 |
| AU2005281705B2 (en) | 2011-03-10 |
| PT1805201E (pt) | 2008-12-31 |
| RS20070075A (sr) | 2008-09-29 |
| CA2577497C (en) | 2012-03-20 |
| BRPI0514976A (pt) | 2008-07-01 |
| RU2007112939A (ru) | 2008-11-10 |
| NZ553266A (en) | 2009-06-26 |
| JP4889644B2 (ja) | 2012-03-07 |
| CA2577497A1 (en) | 2006-03-16 |
| AU2005281705A1 (en) | 2006-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR050732A1 (es) | 15 beta-sustituidos esteroides con actividad estrogenica selectiva | |
| PE20120049A1 (es) | Derivados de 3-anilino-tieno[3, 2-c]piridina como inhibidores de quinasa mek | |
| AR049089A1 (es) | Derivados de adamantil pirrolidin -2- ona como inhibidores de 11-beta hidroxiesteroide deshidrogenasa | |
| EP2080494A4 (en) | EYELIDER OPENING DEVICE WITH CLOTH | |
| AR048778A1 (es) | Derivados de pirrolidinilo como inhibidores de 11-beta hidroxiesteroide deshidrogenasa | |
| JO2672B1 (en) | Progesterone receptor antagonists | |
| EP1726086A4 (en) | UNIVERSAL POWER SUPPLY | |
| FR2884327B3 (fr) | Alimentation avec un dispositif d'affichage de performance | |
| AR024746A1 (es) | Androgenos oralmente activos. | |
| DE602005014891D1 (de) | PYRAZOLOÄ1,5-AÜPYRIMIDINE ALS ANTAGONISTEN DES ADENOSIN-A2a-REZEPTORS | |
| EP1837562A4 (en) | SEALING DEVICE WITH SOUND INSULATING SEAL | |
| CU23818A3 (es) | Antagonistas del receptor de progesterona | |
| PE20141169A1 (es) | Derivados de etinilo | |
| BRPI0513902A (pt) | novos derivados de 4-benzilideno-piperidina | |
| WO2008111632A1 (ja) | ２，２，４－トリメチル－６－フェニル－１，２－ジヒドロキノリン誘導体からなるグルココルチコイド受容体アゴニスト | |
| FR2873863B1 (fr) | Dispositif d'alimentation en energie | |
| FR2875672B1 (fr) | Dispositif electronique avec repartiteur de chaleur integre | |
| CO6150165A2 (es) | Nevos derivados 5,7-disustituidos de [1,3]tiazolo[4,5-d]pirimidin-2 (3h)-ona y su uso en terapia | |
| ECSP077305A (es) | ESTEROIDES SUSTITUIDOS EN LA POSICIÓN 15b QUE TIENEN ACTIVIDAD ESTROGÉNICA SELECTIVA | |
| CN205840401U (zh) | 一种带有桑拿房的淋浴室 | |
| ATE355770T1 (de) | Schnürvorrichtung | |
| FR2918523B1 (fr) | Dispositif d'interface pseudo-differentiel avec circuit d'equilibrage | |
| PE20071170A1 (es) | Compuestos derivados de sulfonamida como moduladores del receptor glucocorticoide | |
| PE20010029A1 (es) | Androgenos oralmente activos | |
| ATE477951T1 (de) | Vorrichtung zum dichten und dämpfen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |